Evaluating the use of a sustained-release intracanalicular dexamethasone insert (Dextenza, Ocular Therapeutix, Inc) in Minimally invasive glaucoma surgery (MIGS)

Administered By

Awarded By

Contributors

Start/End

  • April 14, 2021 - March 14, 2026